Position in LLY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$11,189,483
+$2,584,115 QoQ
Shares Held
9,329
-0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
4.81%
of 13F equity value
Holder Rank
#1,197
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aull & Monroe Investment Management Corp holds $30,785,948 across 9 Drug Manufacturers - General names. LLY ranks #1 (36.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
9,329 | $11,189,483 | |
| 2 | JNJ |
Johnson & Johnson
|
30,562 | $7,761,831 | |
| 3 | ABBV |
AbbVie Inc.
|
14,519 | $3,653,561 | |
| 4 | AMGN |
Amgen Inc
|
9,494 | $3,437,967 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,386 | $2,362,601 | |
| 6 | PFE |
Pfizer Inc
|
38,318 | $922,697 | |
| 7 | NVS |
Novartis AG
|
3,771 | $590,991 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
9,214 | $530,910 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,189,483 | 9,329 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $8,605,368 | 9,356 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $10,282,539 | 9,568 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $7,398,811 | 9,697 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,566,897 | 9,707 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $8,314,435 | 10,067 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,713,824 | 9,992 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $9,029,500 | 10,192 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $9,227,632 | 10,192 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $8,076,780 | 10,382 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $6,285,043 | 10,782 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $5,872,442 | 10,933 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,197,705 | 11,083 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $3,809,558 | 11,093 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,058,263 | 11,093 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,821,026 | 11,817 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,912,483 | 12,067 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $3,455,626 | 12,067 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $3,333,146 | 12,067 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $2,836,600 | 12,277 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $2,828,604 | 12,324 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $2,358,415 | 12,624 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $2,165,204 | 12,824 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,922,927 | 12,991 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $2,132,862 | 12,991 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $2,033,219 | 14,657 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||